Epilepsy Behav by Tian, Niu et al.
Suicide among people with epilepsy: A population-based 
analysis of data from the U.S. National Violent Death Reporting 
System, 17 states, 2003–2011
Niu Tiana,*, Wanjun Cuia, Matthew Zacka, Rosemarie Kobaua, Katherine A. Fowlerb, and 
Dale C. Hesdorfferc
aDivision of Population Health, National Center for Chronic Disease Prevention and Health 
Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, United States
bDivision of Violence Prevention, National Center for Injury Prevention and Control, Centers for 
Disease Control and Prevention, Atlanta, GA 30341, United States
cGH Sergievsky Center and Mailman School of Public Health, Columbia University, New York, NY 
10032, United States
Abstract
Objective—This study analyzed suicide data in the general population from the U.S. National 
Violent Death Reporting System (NVDRS) to investigate suicide burden among those with 
epilepsy and risk factors associated with suicide and to suggest measures to prevent suicide among 
people with epilepsy.
Methods—The NVDRS is a multiple-state, population-based, active surveillance system that 
collects information on violent deaths including suicide. Among people 10 years old and older, we 
identified 972 suicide cases with epilepsy and 81,529 suicide cases without epilepsy in 17 states 
from 2003 through 2011. We estimated their suicide rates, evaluated suicide risk among people 
with epilepsy, and investigated suicide risk factors specific to epilepsy by comparing those with 
and without epilepsy. In 16 of the 17 states providing continual data from 2005 through 2011, we 
also compared suicide trends in people with epilepsy (n = 833) and without epilepsy (n = 68,662).
Results—From 2003 through 2011, the estimated annual suicide mortality rate among people 
with epilepsy was 16.89/100,000 per persons, 22% higher than that in the general population. 
Compared with those without epilepsy, those with epilepsy were more likely to have died from 
suicide in houses, apartments, or residential institutions (81% vs. 76%, respectively) and were 
twice as likely to poison themselves (38% vs. 17%) (P < 0.01). More of those with epilepsy aged 
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40–49 died from suicide than comparably aged persons without epilepsy (29% vs. 22%) (P < 
0.01). The proportion of suicides among those with epilepsy increased steadily from 2005 through 
2010, peaking significantly in 2010 before falling.
Significance—For the first time, the suicide rate among people with epilepsy in a large U.S. 
general population was estimated, and the suicide risk exceeded that in the general population. 
Suicide prevention efforts should target people with epilepsy 40–49 years old. Additional 
preventive efforts include reducing the availability or exposure to poisons, especially at home, and 
supporting other evidence-based programs to reduce mental illness comorbidity associated with 
suicide.
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1. Introduction
In 2014, 59,097 persons died in the United States as a result of violence. Of the 58,348 
violence-related deaths in those ten years old or older, 73% of these deaths were from 
suicide making it one of the leading causes of death and a major public health problem [1].
A recent study indicated that epilepsy, psychiatric disorder, and suicide may be 
pathophysiologically linked [2]. Two studies have estimated a suicide risk about 3 times 
higher in people with epilepsy than in the general population [3,4]. Therefore, suicide 
among people with epilepsy, especially among those with a co-occurring psychiatric 
disorder, has caused a great public health concern.
Although many studies have reported the suicide burden in people with epilepsy [5,6], most 
reported the percentage of suicides among all causes of death in people with epilepsy. 
Differences in the underlying populations, patient selection criteria, sample sizes, study 
designs, and methods of analyses in these studies yielded percentages of suicides varying 
from zero to 70% [5,6]. These differences make it difficult to estimate the overall suicide 
burden in people with epilepsy, and these estimates are more than ten years old. Even though 
suicide rates among people with epilepsy can be calculated indirectly from a few population-
based studies targeting cause-specific mortality [7,8], the suicide rate among people with 
epilepsy in the large general population is still unknown because general population-based 
surveillance systems including both epilepsy and suicide have not been routinely available.
The U.S. National Violent Death Reporting System (NVDRS) is a multiple-state, 
population-based, active surveillance system that is monitored by the U.S. Centers for 
Disease Control and Prevention (CDC) [9]. Currently, NVDRS collects data from 32 US 
states [10]. The NVDRS collects detailed information on the circumstances of violent deaths 
including suicides in defined populations. Its purpose is to obtain accurate, timely, and 
comprehensive data to better understand and ultimately to prevent the occurrence of violent 
deaths in the U.S. [9,10].
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Using the NVDRS, we searched for decedents who died from suicide and had mentions in 
their records of epilepsy or seizures to identify cases of suicide with epilepsy. We also 
estimated the numbers of people with epilepsy in the participating states based on recent 
population-based estimates of U.S. epilepsy prevalence [11,12]. This study was designed to 
answer the following questions among people with epilepsy in the general population who 
died from suicide: What is the burden of suicide? Does suicide occur more often in people 
with epilepsy than in the general population? When, where, and how does suicide occur 
among people with epilepsy? Do the study results provide clues to develop an effective 
preventive strategy to reduce suicide rates in people with epilepsy? We tried to answer these 
questions by 1) estimating suicide rates among people with epilepsy; 2) comparing these 
suicide rates with such rates in the general population; 3) describing selected demographic 
characteristics and the annual trend of suicide occurrence in people with epilepsy; and 4) 
comparing these characteristics and this trend between people with epilepsy who died from 
suicide and people without epilepsy who died from suicide.
2. Materials and methods
2.1. Data source
Currently, NVDRS collects data from 32 states; however, because some states have been a 
part of the system for a short period of time, we decided to study suicide data from the 
NVDRS collected from 2003 through 2011 in 17 states, including examining data from 16 
states that collected data continuously from 2005–2011. The NVDRS is a U.S. population-
based, active surveillance system that collects data on all violent deaths (including suicides) 
occurring in participating states [9]. The NVDRS is the only state-based surveillance system 
in the U.S. that pools data on violence-related deaths from multiple sources into a usable, 
deidentified database. Data come from three primary sources: death certificates, medical 
examiner/coroner reports, and law enforcement records [10]. The NVDRS collects about 
250 unique variables for each death from these information sources. The NVDRS also 
includes data abstraction by abstractors who compose text narratives that describe further 
details about the death, taking into account information from all source documents. The 
NVDRS provides states and communities with comprehensive, accurate, and timely 
information about violent deaths to aid in the development, implementation, and evaluation 
of violence prevention strategies, allowing them to track the progress of these strategies over 
time.
The NVDRS defines suicide as a death resulting from the use of force against oneself when 
a preponderance of the evidence indicates that the use of force was intentional. This category 
also includes deaths of persons who intended only to injure rather than to kill themselves, 
deaths associated with risk-taking behavior without clear intent to inflict fatal injury but 
associated with high risk for death (e.g., “Russian roulette”), and deaths involving only 
others' passive assistance to the decedent (e.g., supplying the means or information needed 
to complete the act). This definition excludes deaths caused by chronic or acute substance 
abuse without the intent to die and deaths attributed to autoerotic behavior (i.e., self-
strangulation during sexual activity). The NVDRS uses the following International 
Tian et al. Page 3
Epilepsy Behav. Author manuscript; available in PMC 2018 August 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Classification of Diseases, 10th edition (ICD-10) codes for suicides: X60–X84 and Y87.0 
[9].
2.2. Study design and population
This cross-sectional study was based on NVDRS data from 2003 through 2011 in 17 states 
(Table 1). By using the method of ICD code and text search (described below), among 
people 10 years old and older, we identified the total number of suicide deaths, the subset of 
these deaths who had co-occurring epilepsy, and the remainder who did not have epilepsy. 
We estimated the suicide rate among people with epilepsy, compared this rate with that in 
the general population, and contrasted the sociodemographic characteristics by comparing 
those who died from suicide in those with and without epilepsy. In a subgroup of 16 of these 
17 states that provided continual data, we determined annual trends of suicide rates from 
2005 through 2011 in people with and without epilepsy (Table 4).
2.3. Identification of suicide deaths in people with epilepsy/seizure in NVDRS
To identify cases of suicide among people with epilepsy/seizure, we searched text from 
death certificates, medical examiner/coroner records, law enforcement reports, and 
abstractors' narratives/descriptors using the following key words and phrases: “epilepsy”, 
“seizure”, “convulsion”, “drop attack”, “falling out spell”, and “staring spell”. These key 
words and phrases have been validated as ways to identify those with possible epilepsy in 
different kinds of population-based surveys [12,13–15]. We also identified suicide cases with 
epilepsy by searching for the following epilepsy/seizure-related ICD-10 codes: G40, G41, 
P90, and R56 in both the underlying cause of death and the first ten multiple conditions 
recoded on the death certificate. Finally, we read abstractors' narratives/descriptors among 
those identified as having epilepsy and dying by the method of poisoning from this search 
and were able to exclude 43 suicide cases whose seizures were not associated with epilepsy 
but with drugs or other poisons that cause seizures (i.e., drug-induced seizures).
2.4. Calculation of suicide rates among people with epilepsy in the general population
We estimated the total number of people with epilepsy in each NVDRS state for each study 
year in the following way. Using findings from an analysis of data from the 2007 National 
Survey of Children's Health [11], we estimated that the current (or active) epilepsy 
prevalence in U.S. children aged 10–17 years is 8.1/1000 persons. The corresponding 
estimated current epilepsy prevalence in U.S. adults 18 years old or older from an analysis of 
2010 U.S. National Health Interview Survey data [12] is 10.0/1000 persons (this prevalence 
did not change in 2013 NHIS). Using these estimates and the age-specific populations of 
those 10 years of age or older in each participating state for each study year [16], we 
estimated the total expected number of people with epilepsy in each state for each study 
year. The annual state-specific suicide rate in people with epilepsy is the proportion of the 
total number of suicide cases in people with epilepsy in each state for each study year from 
the NVDRS to the total expected number of people with epilepsy in each state for each 
study year.
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2.5. Comparing suicide trends between people with and without epilepsy
We estimated trends of annual suicide rates for persons with epilepsy from 17 states 
participating in NVDRS from 2003 through 2011. We also estimated trends of annual 
proportions of suicides with and without epilepsy in the 16 states (all but Ohio) with 
continual data from 2005 through 2011. The annual proportion of suicides is the proportion 
of the number of suicides each year to the total number of suicides for all years from 2005 
through 2011.
2.6. Selected sociodemographic characteristics
To study sociodemographic characteristics associated with violent deaths, NVDRS collects 
information about characteristics such as age, gender, race/ethnicity, education, and marital 
status. It also collects information about the location of injury (e.g., victim's home, 
recreation area, street), the month of injury, and the method of injury (e.g., poisoning, 
hanging/suffocation, firearm).
2.7. Statistical analysis
In those who died from suicide with and without epilepsy, we compared the proportions of 
suicide deaths by the month, the location of death, and the method of injury. We also 
compared the sex-specific proportions of suicide deaths in these two groups by age, race/
ethnicity, education, and marital status. We defined as statistically significant differences in 
proportions of deaths whose two-sided 95% binomial confidence intervals did NOT overlap 
(the statistical significance level = 0.01). We used the Cochran–Armitage trend test to test 
for trends (also the statistical significance level = 0.01). All analyses used SAS version 9.3 
(SAS Institute). Following NVDRS guidance, we suppressed table cells with fewer than five 
deaths but did show table cells with no deaths.
3. Results
From 2003 through 2011 in 17 states, NVDRS identified 82,501 suicide deaths, 972 (1.2%) 
of whom had co-occurring epilepsy. The estimated annual suicide rate among people with 
epilepsy steadily increased to a peak in 2010 before falling (Table 1). The overall average 
suicide rate in people with epilepsy was 16.89/100,000 persons per year.
The percentages of suicide deaths by month of death did not differ between people with 
epilepsy and without epilepsy (Table 2). Most suicide deaths occurred in a house or 
apartment in those with epilepsy (78%) and those without epilepsy (75%), although 
significantly more deaths occurred in houses, apartments, or residential institutions in people 
with epilepsy (81%) than in those without epilepsy (76%; P < 0.01). Poisoning, use of 
firearms, and hanging/strangulation/suffocation were the top three methods of committing 
suicide in both those with and without epilepsy. However, compared with suicide cases in 
those without epilepsy, suicide cases in those with epilepsy were more likely to poison 
themselves (38% vs. 17%; P < 0.01) but less likely to use hanging, strangulation, 
suffocation, or firearms (54% vs. 76%; P < 0.01).
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Most suicides in both those with and those without epilepsy occurred among those 18–59 
years old (84% vs. 76%) and among non-Hispanic whites (86% vs. 85%) (Table 3). 
Compared with those without epilepsy, however, those with epilepsy were more likely to 
commit suicide if they were 30–39 years old (women), 40–49 years old (both sexes), or 50–
59 years old (men) and less likely to commit suicide if they were younger than 30 years old 
or were 70 years old or older (P < 0.01). The percentages of people with epilepsy who 
committed suicide did not differ from that of people without epilepsy by race/ethnicity or 
educational level; about one-third of the suicides in both groups occurred among those with 
the least education. In both those with and without epilepsy, women were more likely than 
men to commit suicide if they had been separated, divorced, or widowed, and men were 
more likely than women to commit suicide if they had never been married (all P-values 
<0.01).
When looking only at the 16 states that provided continual data from 2005 through 2011, 
NVDRS identified 69,495 suicide deaths, 833 (1.2%) of whom had co-occurring epilepsy. 
The trends of suicide deaths steadily increased over time in those with and without epilepsy 
(Table 4 and Fig. 1). In 2010, the percentage of suicide deaths in people with epilepsy 
peaked and significantly exceeded both that of those with epilepsy in previous years and that 
of those without epilepsy in 2010 (both P < 0.01), though these percentages did not differ 
significantly in 2011. This phenomenon is consistent with our observation in Table 1 
indicating that the annual suicide rate among people with epilepsy steadily increased to a 
peak in 2010 before falling.
4. Discussion
Estimates of the suicide burden among people with epilepsy in the general population vary 
substantially, but most of them were based on small populations. Suicide rates can be 
calculated based on the published data from only a few studies with large samples of 
patients with epilepsy, but these studies neither focused on suicide rates [7] nor were 
representative of the general population [8]. Our study fills these gaps. By using the 
population-based NVDRS, this study is the first to estimate suicide rates among people with 
epilepsy in a large, general population of 17 U.S. states participating in NVDRS in the years 
studied. The estimated average annual suicide rate among people with epilepsy in this 
population from 2003 through 2011 was 16.89/100,000 persons. About 1.2% of all suicides 
occurred among people with epilepsy. A prior meta-analysis estimated that 13.5% of all 
suicides occurred among people with epilepsy [17]. We think that this meta-analysis 
overestimated the percentage of suicides among those with epilepsy because many of its 
included studies comprised small samples, highly selected groups of patients, and studies 
from different countries.
Both a large, Danish case–control study within a cohort and a different comprehensive meta-
analysis reported that people with epilepsy have about 3 times the risk of suicide than those 
in the general population [3,4]. Our study indicated that the estimated average annual suicide 
rate across the 17 NVDRS states from 2003 through 2011 among people with epilepsy 
(16.89/100,000 persons) was only 22% higher than that in the general population of the 
same states during the same years (13.84/100,000 per persons) [18]. In contrast with the 
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Danish study, our smaller risk estimate is consistent with other findings that suicide risk 
among people with epilepsy is lower in community than in patient populations [4]. Other 
possible explanations for this smaller risk include variations among countries [5] or 
underidentification (or estimation) of suicides co-occurring with epilepsy (see the detailed 
description below of limitations). However, the strength of the current estimate is that it is 
based on data from about one-third of the U.S. population from the 17 participating U.S. 
states [16]. This study also identified epilepsy and seizures in suicide decedents through a 
broad search in all suicide-related official documents including unique abstractor's 
narratives/descriptors in the NVDRS.
Except for suicide burden and risk, the basic epidemiology of suicide (its distribution and 
determinants) among people with epilepsy in the general population also has been unclear 
[19–21]. In our study, people with epilepsy who died of suicide were more likely to poison 
themselves than those without epilepsy, a finding consistent with those from studies based 
on reports from hospitals and emergency rooms [21–23]. This consistent finding in different 
populations suggests that people with epilepsy who demonstrate a prior risk for suicide 
(suicidal intentions or attempts) may benefit from having caregivers, relatives, and others in 
the home supervise the availability of potentially harmful materials to prevent suicide; this is 
especially important at home [24] since suicide among people with epilepsy in our study 
more often occurred at home than elsewhere.
Because suicide poisonings are more likely to occur among people with epilepsy, it is 
important to understand the drugs involved in this special group. One-third to two-thirds of 
patients with epilepsy who were proven or suspected suicides and reported in previous 
studies overdosed on antiepileptic drugs [21,25]. In the current study, a search of 36 
antiepileptic drugs (see supplemental document 1 online) in the NVDRS data files 
(including abstractor's narrative and descriptor) found that only 20/332 (6%) of those with 
epilepsy who poisoned themselves used antiepileptic drugs to commit suicide (detailed 
results not shown). This difference in estimates between our findings and previous findings 
may result from different sample sizes, study designs, and especially selected patient 
populations.
Another important finding from this study is that, compared with people without epilepsy, 
those with epilepsy aged 40–49 are more likely, and those aged 18–29 or 70 years old or 
older are less likely, to commit suicide. In the general population, even though epilepsy 
incidence is higher in children and older adults [26,27], the highest epilepsy prevalence 
occurs in those 35 through 64 years old [10], which may account for our results. Other 
factors in these middle-age groups may also contribute to this increased risk. Obviously, 
further advocacy of awareness of suicide risk in these vulnerable age groups is needed to 
prevent suicide deaths.
In both those with epilepsy and those without epilepsy, never married men died from suicide 
more often than never married women, and separated, divorced, or widowed women died 
from suicide more often than separated, divorced, or widowed men. These findings are 
consistent with other studies indicating that less social support is a major risk factor for 
morbidity as well as mortality [28]. Because people with epilepsy are more likely to never 
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have been married than those without epilepsy [29,30], decreased social support [31] may 
make them more prone to psychological and physical ailments that could cause a higher risk 
of suicide [32]. However, overall marital status did not differ between those with and 
without epilepsy when we combined men and women who died from suicide.
Finally, from 2003 to 2011, the estimated annual suicide rate among people with epilepsy 
steadily increased over time, peaking in 2010, before falling. The proportion of annual 
suicides among all suicides in those with epilepsy also followed the same pattern, peaking in 
2010, significantly higher than that in those with epilepsy in the previous years and also 
significantly higher than this proportion in those without epilepsy in 2010. The estimated 
U.S. epilepsy prevalence overall rose from 2007 until 2010 and 2011, where it plateaued 
[26]. Although consistent with our trend in the proportion of annual suicides among all 
suicides in those with epilepsy, these changes in prevalence would not account for changes 
in estimated annual suicide rates using estimated populations with epilepsy as the 
denominators. Another explanation, the impact of the recent U.S. economic recession, is 
possible; a trend analysis from 54 countries (including 18 Western Hemisphere countries) 
has shown that, after the 2008 economic crisis, rates of suicide increased, particularly in men 
and in countries with higher job losses [33]. The economic crisis and its consequent 
unemployment, poverty, debt, and diminished public welfare could lead to depression [34], a 
major risk factor for suicide in people with epilepsy [35]. People with epilepsy have less 
education, a lower household income, poorer health status, and a higher unemployment rate 
than those without epilepsy [36], and depression affects 30–50% of individuals with epilepsy 
[37–39]. This socioeconomically and mentally vulnerable group therefore might be more 
subject to the negative impact of the 2008 U.S. economic crisis than the general population 
leading to this unusual peak in the suicide rate. However, further research is needed to 
confirm or refute this hypothesis.
This study has several limitations. First of all, the identification of epilepsy and seizure 
among suicide cases could have misclassified some suicide cases. In particular, the search 
for epilepsy/seizure in NVDRS may profoundly undercount the number of persons who died 
from suicide with epilepsy because suicide data from the NVDRS do not typically include 
previous medical records for the decedents; therefore, an epilepsy/seizure diagnosis may be 
missed unless it came up when investigators of violent deaths talked to those who may have 
known the decedent or may not have been recorded if the diagnosis was not viewed as a 
potential factor associated with the individual's death. On the other hand, some of the 
nonspecific words and phrases we searched for to identify those with epilepsy/seizure (e.g., 
“falling out spell”, “staring spell”, “drop attack”) could have referred to other conditions and 
thus lead to overestimates of the number of suicide cases attributed to persons with epilepsy. 
Second, we estimated the expected number of people with epilepsy in each state as 
denominators for our suicide rates among those with epilepsy based on two, national age-
specific prevalence rate estimates, which may not be appropriate because incidence may 
differ by states. Third, NVDRS included data from only 17 states, not from the whole U.S. 
population. Fourth, the number of suicides was too few to compare suicide rates by various 
sociodemographic factors, such as race/ethnicity and socioeconomic status. Fifth, about half 
of the reports of persons who died from suicide lacked information about education. Finally, 
most people who die by suicide have comorbid psychiatric disorders [40]. Depression 
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remains an important but underdiagnosed, common comorbidity of epilepsy that contributes 
to premature mortality seen in this population [41]. Further study is needed to examine 
associations between epilepsy–suicide and prior history of mental illness.
5. Conclusion
This is the first study to describe the basic epidemiology among people with epilepsy who 
died from suicide by systematically investigating the suicide burden and the 
sociodemographic characteristics of people with epilepsy in the general population. This 
study used large, population-based data from a unique U.S. data system, the NVDRS, which 
includes most suicides (from 2003 through 2011 in the 17 U.S. states; about one-third of the 
U.S. population) and comprehensive information that allows the identification of persons 
with epilepsy who died from suicide. Among those with epilepsy, this study estimated the 
suicide rate, evaluated the risk of suicide compared with that in the general population, 
investigated the suicide risk factors by socioeconomic characteristics, and described suicide 
trends.
To reduce suicide risk, in addition to those prevention measures proposed in the 
abovementioned discussion, providers should screen for and treat depression in people with 
epilepsy following appropriate recommendations and guidelines [42,43]. Suicide Safe, the 
US Substance Abuse and Mental Health Service Administration's suicide prevention app, 
helps providers integrate suicide prevention strategies into their practice [44]. Epilepsy 
health and social service providers can consider implementing evidence-based depression 
treatment interventions for adults with epilepsy and comorbid depression [45,46]. To prevent 
suicide among people with epilepsy, caregivers and other members of the public can 
participate in Mental Health First Aid, an evidence-based program that teaches people about 
mental illness and its symptoms and how to recognize and intervene during a mental health 
crisis [47]. Mental Health First Aid training is available in communities throughout the 
United States.
Finally, population-based surveillance targeting both epilepsy and suicide could be enhanced 
to allow further study of the epidemiology of suicide among different racial groups with 
epilepsy in the U.S. nationwide.
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Fig. 1. 
Annual percentage of suicides among all suicides (10 years old and older, 2005 to 2011), by 
epilepsy status.
*P < 0.01 when comparing to previous years within the same group or comparing to people 
without epilepsy in 2010.
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